Impact of leptin and leptin-receptor gene polymorphisms on serum lipids in Japanese obese children

T Okada1, T Ohzeki, Y Nakagawa

  • 1Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan. tomokada@med.nihon-u.ac.jp

Insights

Leptin receptor (LEPR) gene variants, specifically Lys109Arg and Ser343Ser, are linked to altered serum lipid profiles and body weight in obese Japanese children. Leptin gene polymorphisms showed no such associations.

Area of Science:

  • Genetics
  • Pediatrics
  • Metabolic Disorders

Background:

  • Leptin plays a role in regulating body weight and metabolism.
  • Serum lipid profile is a critical indicator of cardiovascular health.
  • Obesity in children is associated with dyslipidemia and increased health risks.

Purpose of the Study:

  • To investigate the association between serum lipids and polymorphisms in the leptin and leptin receptor (LEPR) genes in obese Japanese children.
  • To explore the relationship between these gene variations and anthropometric measurements.

Main Methods:

  • A cohort of 136 obese Japanese children (aged 5-17) was studied.
  • Polymorphisms in the leptin gene [(+19)A>G, (-2548)G>A, (-188)C>A, (-633)C>T] and LEPR gene [Lys109Arg, Gln223Arg, Pro1019Pro, Ser343Ser] were analyzed using PCR-RFLP.
  • Serum lipid profiles and relative weight were measured.

Main Results:

  • No significant associations were found between leptin gene polymorphisms and serum lipid profiles.
  • LEPR gene polymorphisms Lys109Arg and Ser343Ser showed significant associations with lipid profiles.
  • Arg109Arg homozygotes had lower total and LDL cholesterol, while Ser343Ser homozygotes had lower TG levels.
  • LEPR gene polymorphisms were also associated with relative weight.

Conclusions:

  • LEPR gene polymorphisms, particularly Lys109Arg and Ser343Ser, may influence serum lipid profiles in obese children.
  • These findings suggest a potential genetic contribution of the LEPR gene to lipid metabolism in pediatric obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...